Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

806
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
806
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

261
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
261
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

218
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
218
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

365
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
365
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

342
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
342
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

312
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding opioid use for noncancer pain: a community pharmacy-based observational study of patient profiles and experiences.

Pain·2026
Same author

Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III Study.

Neurology and therapy·2026
Same author

Diagnostic tests and headache misdiagnoses in individuals with resistant and refractory migraine - data from the REFINE study.

Cephalalgia : an international journal of headache·2026
Same author

Correction: What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

The journal of headache and pain·2026
Same author

Over 600 million people aged 18-65 will have headache tomorrow: global 1-day prevalence and recall bias from a meta-analysis of individual participant data (N = 38,512) from the general populations of 15 countries.

The journal of headache and pain·2026
Same author

What's a migraine day? Towards a consensus definition for clinical care and research - a Delphi panel-based study.

The journal of headache and pain·2026

Related Experiment Video

Updated: Feb 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.8K

Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Nicolas Vandenbussche1, Domenico Laterza2, Marco Lisicki3

  • 1Headache Group, Department of Basic and Clinical Neuroscience, King's College London, and NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital, Denmark Hill, London, SE5 9PJ, UK. Nicolas.vandenbussche@kcl.ac.uk.

The Journal of Headache and Pain
|July 14, 2018
PubMed
Summary

Medication overuse headache (MOH) is a global issue contributing to headache chronification and significant disease burden. This review examines MOH

Keywords:
Medication-overuse headacheNosologyReview

More Related Videos

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.4K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.8K

Related Experiment Videos

Last Updated: Feb 7, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

18.8K
Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research
04:37

Author Spotlight: Integrating Mechanical and Biological Analysis in Tendinopathy Research

Published on: March 1, 2024

1.4K
Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache
05:40

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

9.8K

Area of Science:

  • Neurology
  • Clinical Medicine
  • Public Health

Background:

  • Medication overuse headache (MOH) is a widespread problem, significantly contributing to the chronification of primary headache disorders.
  • The global burden of MOH is substantial, encompassing high healthcare costs and associated comorbidities.
  • MOH is classified as a secondary headache disorder in the International Classification of Headache Disorders, though often viewed as a complication of primary headaches.

Purpose of the Study:

  • To provide a comprehensive overview of medication overuse headache.
  • To explore the historical background, epidemiology, phenomenology, pathophysiology, and treatment of MOH.
  • To identify and discuss current debates and unanswered questions surrounding MOH.

Main Methods:

  • This study is a review of existing literature on medication overuse headache.
  • The review synthesizes information on the historical context, prevalence, clinical features, underlying mechanisms, and therapeutic strategies for MOH.
  • It also addresses ongoing controversies and knowledge gaps in the field.

Main Results:

  • Medication overuse is a key factor in the development and persistence of chronic headache disorders.
  • MOH presents unique epidemiological and phenomenological characteristics.
  • Current understanding of MOH pathophysiology is evolving, with various treatment approaches available.

Conclusions:

  • Medication overuse headache is a distinct entity with significant public health implications.
  • Further research is needed to address current debates and unanswered questions regarding MOH.
  • Effective management strategies are crucial for reducing the burden of MOH.